
Grayscale has taken a big step to widen institutional access to crypto.
On September 8, the asset manager filed an S-1 with the U.S. Securities and Exchange Commission (SEC) for a Chainlink (LINK) exchange-traded fund (ETF). If approved, the fund would give investors regulated exposure to one of the most important networks in decentralized finance (DeFi).
This filing shows Grayscale’s focus is no longer limited to Bitcoin and Ethereum. It comes just weeks after Bitwise submitted its own Chainlink ETF application in August, signaling growing competition to bring LINK to traditional markets.
The move lands at a time when the SEC has delayed several other ETF decisions, including WisdomTree’s. Yet the steady flow of filings suggests demand for crypto ETFs, especially those tied to leading altcoins, is only increasing.
Chainlink’s fundamentals back the attention it’s getting. The oracle network secures more than $59.56 billion in value and powers over 458 protocols, cementing its role as a core piece of blockchain infrastructure.
It has also been featured in Canary Capital’s “Made in USA” crypto list, a curated selection of top U.S.-related assets. And with Chainlink driving conversations around real-world asset (RWA) tokenization, interest in LINK has only grown.
For Grayscale, this ETF push represents more than another product launch. It shows a clear move to expand regulated investment opportunities beyond Bitcoin and Ethereum.
If approved, the Chainlink ETF could open the door for more altcoin-based funds and mark another milestone for crypto’s path into mainstream finance.
Check back on Coinpedia for more updates!
Bittensor (TAO) price has seen a strong rally over the past few days, but the…
The top five RWA crypto projects are suddenly back in the spotlight and not quietly.…
Ripple has announced a major expansion in Brazil, strengthening its role in one of the…
Most altcoin traders are asking the wrong question. They want to know when altseason starts.…
When BlackRock launched its BUIDL tokenized money market fund in 2024, and Franklin Templeton brought…
Core Scientific just finalized a $500 million loan facility backed directly by Morgan Stanley, with…